These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Response to Berg et al. 'Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review'. Brown TT; Qaqish RB AIDS; 2007 Aug; 21(13):1830-1. PubMed ID: 17690589 [No Abstract] [Full Text] [Related]
44. HIV clinical trial design for antiretroviral development: moving forward. Chan-Tack KM; Struble KA; Morgensztejn N; Murray JS; Gulick R; Cheng B; Weller I; Miller V AIDS; 2008 Nov; 22(18):2419-27. PubMed ID: 19005265 [No Abstract] [Full Text] [Related]
45. Does HIV cause cardiovascular disease? Carr A; Ory D PLoS Med; 2006 Nov; 3(11):e496. PubMed ID: 17132070 [TBL] [Abstract][Full Text] [Related]
46. Anti-HIV agents. When is it best to start HAART? TreatmentUpdate; 2009; 21(3):2. PubMed ID: 19623724 [No Abstract] [Full Text] [Related]
47. [Toxidermia during antiretroviral therapy in Conakry, Guinea]. Cisse M; So N; Keita M; Soumah MM; Camara A Med Trop (Mars); 2008 Apr; 68(2):203. PubMed ID: 18630056 [No Abstract] [Full Text] [Related]
48. [Causes of death in HIV patients]. Bühler S; Söllner J; Seybold U; Bogner JR MMW Fortschr Med; 2009 Apr; 151(18):56-7. PubMed ID: 19769078 [No Abstract] [Full Text] [Related]
49. If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era. Baker JV; Henry K Ann Intern Med; 2011 Apr; 154(8):563-5. PubMed ID: 21502654 [No Abstract] [Full Text] [Related]
50. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective]. Wepner U MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085 [No Abstract] [Full Text] [Related]
51. Haiti trial supports starting antiretroviral therapy earlier. AIDS Patient Care STDS; 2009 Jul; 23(7):577. PubMed ID: 19621995 [No Abstract] [Full Text] [Related]
52. Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes. Prescrire Int; 2009 Jun; 18(101):104. PubMed ID: 19637415 [TBL] [Abstract][Full Text] [Related]
53. [Compliance to antiretroviral treatment in children in Brazzaville, Congo]. Samba Louaka C; Mabiala Babela JR; Mouko A; Senga P Arch Pediatr; 2009 May; 16(5):486-8. PubMed ID: 19329290 [No Abstract] [Full Text] [Related]
54. [How long is the anti-retroviral therapy?]. Martín MT; Codina C Farm Hosp; 2007; 31(4):197-9. PubMed ID: 18052612 [No Abstract] [Full Text] [Related]
55. PEP must begin early. AIDS Patient Care STDS; 2006 May; 20(5):379-80. PubMed ID: 16706712 [No Abstract] [Full Text] [Related]
56. [New groups of drugs for HIV infection therapy]. Rozsypal H Klin Mikrobiol Infekc Lek; 2008 Dec; 14(6):223-4. PubMed ID: 19378497 [No Abstract] [Full Text] [Related]
57. Readiness for HIV treatment. Enriquez M; McKinsey D Am J Nurs; 2004 Oct; 104(10):81-4. PubMed ID: 15492547 [No Abstract] [Full Text] [Related]
58. [Encephalopathy in HIV patients on antiretroviral therapy]. Kishida S Rinsho Shinkeigaku; 2015; 55(6):435-6. PubMed ID: 26103821 [No Abstract] [Full Text] [Related]
59. Short-course antiretroviral therapy in primary HIV infection. Lehmann C; Wyen C; Fätkenheuer G N Engl J Med; 2013 May; 368(21):2036. PubMed ID: 23697519 [No Abstract] [Full Text] [Related]
60. Prioritizing antiretrovirals for second-line therapy in resource-limited countries. Naidoo K AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]